Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer-Reference-Cited by-同舟云学术

Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer

Published:2020-12-14 Issue:2 Volume:10 Page:626-633
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Shimokawa Tsuneo¹^ORCID,Yamada Kazuhiko²,Tanaka Hiroshi³,Kubota Kaoru⁴,Takiguchi Yuichi⁵^ORCID,Kishi Kazuma⁶,Saito Haruhiro⁷,Hosomi Yukio⁸,Kato Terufumi⁷,Harada Daijiro⁹,Otani Sakiko¹⁰,Kasai Takashi¹¹,Nakamura Yoichi¹¹,Misumi Toshihiro¹²,Yamanaka Takeharu¹²,Okamoto Hiroaki¹

Affiliation:

1. Department of Respiratory Medicine Yokohama Municipal Citizen’s Hospital Kanagawa Japan

2. Department of Respiratory Medicine Shin Koga Hospital Fukuoka Japan

3. Department of Internal Medicine Niigata Cancer Center Hospital Niigata Japan

4. Department of Pulmonary Medicine, Infection and Oncology Nippon Medical School Tokyo Japan

5. Department of Medical Oncology Chiba University Chiba Japan

6. Department of Respiratory Medicine Toho University Tokyo Japan

7. Department of Thoracic Oncology Kanagawa Cancer Center Kanagawa Japan

8. Department of Respiratory Medicine Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan

9. Department of Thoracic Oncology Shikoku Cancer Center Ehime Japan

10. Division of Medical Oncology Kanazawa University Cancer Research Institute Ishikawa Japan

11. Department of Respiratory Medicine Tochigi Cancer Center Tochigi Japan